Abstract:The development of CRISPR-based gene-editing technologies has brought an unprecedented revolution in the field of genome engineering. Cas12a, a member of the Class 2 Type V CRISPR-associated endonuclease family distinct from Cas9, has been repurposed and developed into versatile gene-editing tools with distinct PAM recognition sites and multiplexed gene targeting capability. However, with current CRISPR/Cas12a technologies, it remains a challenge to perform efficient and precise genome editing of long sequences in mammalian cells. To address this limitation, we utilized phage recombination enzymes and developed an efficient CRISPR/Cas12a tool for multiplexed precision editing in mammalian cells. Through protein engineering, we were able to recruit phage recombination proteins to Cas12a to enhance its homology-directed repair efficiencies. Our phage-recombination-assisted Cas12a system achieved up to 3-fold improvements for kilobase-scale knock-ins in human cells without compromising the specificity of the enzyme. The performance of this system compares favorably against Cas9 references, the commonly used enzyme for gene-editing tasks, with improved specificity. Additionally, we demonstrated multi-target editing with similar improved activities thanks to the RNA-processing activity of the Cas12a system. This compact, multi-target editing tool has the potential to assist in understanding multi-gene interactions. In particular, it paves the way for a gene therapy method for human diseases that complements existing tools and is suitable for polygenic disorders and diseases requiring long-sequence corrections.

Improved Prime Editors Enable Pathogenic Allele Correction and Cancer Modelling in Adult Mice

A prime editor mouse to model a broad spectrum of somatic mutations in vivo

Development of a Highly Efficient Prime Editor System in Mice and Rabbits.

Application of prime editing to the correction of mutations and phenotypes in adult mice with liver and eye diseases

Prime editing in mice reveals the essentiality of a single base in driving tissue-specific gene expression

Improved split prime editors enable efficient in vivo genome editing

A robust and inducible precise genome editing via an all-in-one prime editor in human pluripotent stem cells

Development of a Versatile Nuclease Prime Editor with Upgraded Precision

Treatment of a genetic liver disease in mice through transient prime editor expression

Dual-AAV split prime editor corrects the mutation and phenotype in mice with inherited retinal degeneration

Cost-effective Generation of A-to-G Mutant Mice by Zygote Electroporation of Adenine Base Editor Ribonucleoproteins.

Enhanced prime editing systems by manipulating cellular determinants of editing outcomes

Efficient prime editing in mouse brain, liver and heart with dual AAVs

Broadening prime editing toolkits using RNA-Pol-II-driven engineered pegRNA

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

In vivo prime editing of a metabolic liver disease in mice

Improved nuclease-based prime editing by DNA repair modulation and pegRNA engineering

Genetic Modification of Mice Using Prime Editing

A split prime editor with untethered reverse transcriptase and circular RNA template

Efficient and multiplexed somatic genome editing with Cas12a mice

Enrichment of Allelic Editing Outcomes by Prime Editing in Induced Pluripotent Stem Cells